{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:32:53Z","timestamp":1771461173584,"version":"3.50.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Pathol"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1093\/ajcp\/aqw181","type":"journal-article","created":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T16:28:31Z","timestamp":1479227311000},"page":"578-584","source":"Crossref","is-referenced-by-count":5,"title":["Survey of Institutional Policies for Provision of \u201cCMV-Safe\u201d Blood in Ontario"],"prefix":"10.1093","volume":"146","author":[{"given":"Laura","family":"Finlay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pria","family":"Nippak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Tiessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winston","family":"Isaac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannie","family":"Callum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Cserti-Gazdewich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,11,15]]},"reference":[{"key":"2017011705551656000_146.5.578.1","first-page":"441","article-title":"Clinical effects of leucoreduction of blood transfusions","volume":"69","author":"Bilgin","year":"2011","journal-title":"Neth J Med"},{"key":"2017011705551656000_146.5.578.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2005.02.002"},{"key":"2017011705551656000_146.5.578.3","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/147.6.974"},{"key":"2017011705551656000_146.5.578.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(81)80662-2"},{"key":"2017011705551656000_146.5.578.5","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1046\/j.1537-2995.2001.41121591.x","article-title":"Residual subset population analysis in WBC-reduced blood components, using real time PCR quantification of specific mRNA","volume":"41","author":"Pennington","year":"2001","journal-title":"Transfusion"},{"key":"2017011705551656000_146.5.578.6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1309\/PVFR-DDWE-302T-WFA1","article-title":"Cytomegalovirus infectivity in whole blood following leukocyte reduction by filtration","volume":"1","author":"Lipson","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"2017011705551656000_146.5.578.7","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1111\/j.1537-2995.2007.01494.x","article-title":"Prevention of transfusion-transmitted cytomegalovirus: reactivation of the debate?","volume":"47","author":"Drew","year":"2007","journal-title":"Transfusion"},{"key":"2017011705551656000_146.5.578.8","doi-asserted-by":"publisher","DOI":"10.1080\/00365540110080412"},{"key":"2017011705551656000_146.5.578.9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3143"},{"key":"2017011705551656000_146.5.578.10","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1111\/j.1537-2995.2012.03739.x","article-title":"Safety of leukoreduced, cytomegalovirus (CMV)\u2013untested components in CMV-negative allogeneic human progenitor cell transplant recipients","volume":"52","author":"Nash","year":"2012","journal-title":"Transfusion"},{"key":"2017011705551656000_146.5.578.11","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1111\/j.1537-2995.2011.03203.x","article-title":"Transmission of cytomegalovirus (CMV) infection by leukoreduced blood products not tested for CMV antibodies: a single-centre prospective study in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"51","author":"Thiele","year":"2011","journal-title":"Transfusion"},{"key":"2017011705551656000_146.5.578.12","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1537-2995.2009.02486.x","article-title":"Direct assessment of cytomegalovirus transfusion-transmitted risks after universal leukoreduction","volume":"50","author":"Wu","year":"2010","journal-title":"Transfusion"},{"key":"2017011705551656000_146.5.578.13","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.bbmt.2013.09.013","article-title":"Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction?","volume":"19","author":"Kekre","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"2017011705551656000_146.5.578.14","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12103"},{"key":"2017011705551656000_146.5.578.15","unstructured":"New Zealand Blood Services policy on the provision of CMV antibody negative blood components. 2011. http:\/\/www.nzblood.co.nz\/assets\/transfusion-medicine\/pdfs\/nzbs-policy-on-the-provision-of-cmv-antibody-negati-ve-blood-components-111p067.pdf. Accessed December 4, 2015."},{"key":"2017011705551656000_146.5.578.16","unstructured":"UK Department of Health, SaBTO Cytomegalovirus Steering Committee. SaBTO report of the cytomegalovirus steering group. Cytomegalovirus tested blood components position statement (March 8, 2012). http:\/\/www.gov.uk\/government\/publications\/sabto-report-of-the-cytomegalovirus-steering-group. Accessed December 4, 2015."},{"key":"2017011705551656000_146.5.578.17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1423-0410.2009.01228.x","article-title":"Survey of current practice for prevention of transfusion-transmitted cytomegalovirus in the United States: leucoreduction vs. cytomegalovirus-seronegative","volume":"98","author":"Smith","year":"2010","journal-title":"Vox Sang"},{"key":"2017011705551656000_146.5.578.18","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1182\/blood.V86.9.3598.bloodjournal8693598","article-title":"A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant","volume":"86","author":"Bowden","year":"1995","journal-title":"Blood"},{"key":"2017011705551656000_146.5.578.19","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/jamapediatrics.2014.1360","article-title":"Blood transfusion and breast milk transmission of cytomegalovirus in very low-birth-weight infants: a prospective cohort study","volume":"168","author":"Josephson","year":"2014","journal-title":"JAMA Pediatr"},{"key":"2017011705551656000_146.5.578.20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1542\/peds.72.3.295","article-title":"Cytomegalovirus infection of breast milk and transmission in infancy","volume":"72","author":"Dworsky","year":"1983","journal-title":"JAMA Pediatr"},{"key":"2017011705551656000_146.5.578.21","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.3.1.6"},{"key":"2017011705551656000_146.5.578.22","doi-asserted-by":"publisher","DOI":"10.1287\/mnsc.1060.0692"},{"key":"2017011705551656000_146.5.578.23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.15.1969"},{"key":"2017011705551656000_146.5.578.24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199902113400601"},{"key":"2017011705551656000_146.5.578.25","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/j.1537-2995.2010.02879.x","article-title":"Hitting the \"tipping point\" of TRICC?","volume":"50","author":"Cserti-Gazdewich","year":"2010","journal-title":"Transfusion"},{"key":"2017011705551656000_146.5.578.26","doi-asserted-by":"publisher","DOI":"10.1053\/tmrv.2001.19946"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T18:20:30Z","timestamp":1657736430000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article-lookup\/doi\/10.1093\/ajcp\/aqw181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,11,15]]},"published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.1093\/ajcp\/aqw181"],"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqw181","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}